Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass Balance Study of [14C]-Tigulixostat in Healthy Males
NCT04070846Phase 1Completed
- Sponsor
- LG Chem
- Start
- Feb 2020
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of tigulixostat in gout and hyperuricemia, sponsored by LG Chem. Primary endpoints: Mass balance recovery of total radioactivity in whole blood and plasma and Mass balance recovery of total radioactivity in whole urine and feces. Started Feb 2020; status: completed.
02
Drugs
tigulixostat
03
Conditions
gouthyperuricemia
Beyond the preview
Go deeper on NCT04070846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04070846.